Research News

Home » Research News

Clinical trial will test use of MRI to improve prostate cancer diagnosis and management

Clinical Trials / By / / 1 minute of reading

The Movember Foundation, the Ontario Institute for Cancer Research and Prostate Cancer Canada announced $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer. The primary objective is to determine whether MRI imaging can spare some men from undergoing a biopsy and avoid the possible associated side effects. The trial will be led by Dr. Laurence Klotz of the Sunnybrook Research Institute in Toronto. Read the article.

Clinical trial will test use of MRI to improve prostate cancer diagnosis and management Read More »

A Breakthrough Test for Prostate Cancer

Diagnosis / By / / 1 minute of reading

Every four minutes, prostate cancer kills someone, somewhere around the world. Researchers at Cambridge Oncometrix, are developing a simple test that will detect the disease early. Dmitry Soloviev is one the scientists who’s helping to develop a test that can indicate the presence of cancer cells. Dr. Dmitry is the principal scientist at Oncometrix. Watch his video and learn more about this innovative test and how scientists are working to develop it further. Read the article.

A Breakthrough Test for Prostate Cancer Read More »

Video: “Imaging Tests”

Videos, Awareness Nights, Diagnosis, Technology / By / / 1 minute of reading

July 2016 Awareness Night Imaging Tests Dr. Masoom Haider, MD, FRCPC Senior scientist, Physical Sciences, Odette Cancer Research Program Sunnybrook Research Institute Chief, Department of medical imaging, Sunnybrook Health Sciences Centre Professor, Department of medical imaging, University of Toronto Clinician scientist, Ontario Institute for Cancer Research   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 44:07 minutes

Video: “Imaging Tests” Read More »

Questions to Ask Before Participating in a Prostate Cancer Clinical Trial

Clinical Trials / By / / 1 minute of reading

Several key questions that a participant will want answered before enrolling in a clinical trial are listed here. It is important that people learn as much as possible prior to entering a trial, and to thoroughly discuss the study with a doctor and with the study team. Read the article.

Questions to Ask Before Participating in a Prostate Cancer Clinical Trial Read More »

Revolutionary new drug could help sex lives of thousands of prostate cancer suffers

Research News / By / / 1 minute of reading

A revolutionary new light activated drug will spare thousands of men with prostate cancer from the misery of ruined sex lives. The treatment involves injecting a light sensitive drug into the blood stream. When infra red light is shone on the prostate, it destroys the blood vessels feeding the tumour, killing it. Read the article.

Revolutionary new drug could help sex lives of thousands of prostate cancer suffers Read More »

Common prostate cancer treatments suppress immune response and may promote relapse

Research News / By / / 1 minute of reading

Researchers using mouse models found that many medical androgen deprivation therapies (ADTs) – the most commonly used nonsurgical treatments for prostate cancer – may suppress patients’ adaptive immune responses, preventing immunotherapies from working if both treatments are used but not sequenced properly. Read the article.

Common prostate cancer treatments suppress immune response and may promote relapse Read More »

Scroll to Top